Amarin Corporation PLC
NASDAQ:AMRN
Amarin Corporation PLC
NASDAQ:AMRN
Price:
14.8
USD
2.28%
Market Cap:
$307.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Amarin Corporation PLC
NASDAQ:AMRN
|
IE |
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
KR |
|
Warby Parker Inc
NYSE:WRBY
|
US |
|
A
|
Ai Robotics Inc
TSE:247A
|
JP |
|
S
|
Shinkong Synthetic Fiber Corp
TWSE:1409
|
TW |
|
M
|
Mitsubishi Pencil Co Ltd
TSE:7976
|
JP |
|
Tokyo Electric Power Company Holdings Inc
TSE:9501
|
JP |
|
Z
|
Ziel Home Furnishing Technology Co Ltd
SZSE:301376
|
CN |
|
M
|
Mast Energy Developments PLC
LSE:MAST
|
UK |
|
DT Midstream Inc
NYSE:DTM
|
US |
|
Pacific Textiles Holdings Ltd
HKEX:1382
|
HK |
Relative Value
The Relative Value of one
AMRN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 14.8 USD,
Amarin Corporation PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AMRN Relative Value
HIDDEN
Multiples Across Competitors
AMRN Competitors Multiples
Amarin Corporation PLC Competitors
Amarin Corporation PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IE |
|
Amarin Corporation PLC
NASDAQ:AMRN
|
301.1m USD | 1.4 | -7.9 | -0.5 | -0.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD | 6 | 87.5 | 14.5 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD | 5.2 | 24.8 | 14.4 | 14.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD | 5.9 | 20.3 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 9.7 | 29.4 | 22.1 | 23.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
35.7B EUR | 10.4 | 33.5 | 36.3 | 37 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
